JEAN JACQUES BIENAIME Insider Trading $BMRN BIOMARIN PHARMACEUTICAL INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JEAN JACQUES BIENAIME.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JEAN JACQUES BIENAIME. JEAN JACQUES BIENAIME is Director in INCYTE CORP ($INCY) and Chief Executive Officer in BIOMARIN PHARMACEUTICAL INC ($BMRN) and Director in VITAL THERAPIES INC ($VTL).
JEAN JACQUES BIENAIME in BIOMARIN PHARMACEUTICAL INC
Trading Symbol: BMRNIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JEAN JACQUES BIENAIME: Chief Executive Officer
Holdings: 304,839 shares
Current Value: $27,103,235
Latest Transaction: Jun 23 2021
$BMRN Market Capitalization: $15.63B
$BMRN Previous Close: $88.91
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JEAN JACQUES BIENAIME in BIOMARIN PHARMACEUTICAL INC
Sentiment: All, BMRN, VTL, INCY
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 112,500 | |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 122,500 | |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.29 | 10,000 | 822,887 | 290,031 | 300 K to 290 K (-3.33 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.58 | 10,000 | 825,811 | 290,031 | 300 K to 290 K (-3.33 %) |
Apr 25 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 132,500 | |
Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.65 | 10,000 | 836,458 | 290,031 | 300 K to 290 K (-3.33 %) |
Apr 24 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 300,031 | 290 K to 300 K (+3.45 %) |
Apr 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 107,000 | |
Apr 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 290,031 | 289 K to 290 K (+0.35 %) |
Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 108,000 | |
Apr 03 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 289,031 | 288 K to 289 K (+0.35 %) |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 109,000 | |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.86 | 1,000 | 17,860 | 10,000 | |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 288,031 | 287 K to 288 K (+0.35 %) |
Mar 30 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.86 | 1,000 | 17,860 | 287,031 | 286 K to 287 K (+0.35 %) |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 110,000 | |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 111,000 | |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 286,031 | 285 K to 286 K (+0.35 %) |
Mar 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 285,031 | 284 K to 285 K (+0.35 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 112,000 | |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 81.36 | 13,075 | 1,063,782 | 284,031 | 297.1 K to 284 K (-4.40 %) |
Mar 26 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 297,106 | 296.1 K to 297.1 K (+0.34 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 15,000 | 578,850 | 142,500 | |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.26 | 15,000 | 1,248,854 | 296,106 | 311.1 K to 296.1 K (-4.82 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 15,000 | 578,850 | 311,106 | 296.1 K to 311.1 K (+5.07 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 83.57 | 148,190 | 12,384,238 | 148,190 | |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 15,000 | 578,850 | 157,500 | |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 46,340 | 0 | 296,106 | 249.8 K to 296.1 K (+18.55 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 83.57 | 14,908 | 1,245,862 | 249,766 | 264.7 K to 249.8 K (-5.63 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.73 | 15,000 | 1,270,901 | 264,674 | 279.7 K to 264.7 K (-5.36 %) |
Mar 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 15,000 | 578,850 | 279,674 | 264.7 K to 279.7 K (+5.67 %) |
Mar 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 1,000 | 14,390 | 113,000 | |
Mar 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 79.86 | 8,542 | 682,164 | 264,674 | 273.2 K to 264.7 K (-3.13 %) |
Mar 06 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 1,000 | 14,390 | 273,216 | 272.2 K to 273.2 K (+0.37 %) |
Feb 28 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 45,722 | 0 | 272,216 | 226.5 K to 272.2 K (+20.19 %) |
Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 172,500 | |
Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.63 | 10,000 | 846,285 | 226,494 | 236.5 K to 226.5 K (-4.23 %) |
Feb 20 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 236,494 | 226.5 K to 236.5 K (+4.42 %) |
Jan 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 182,500 | |
Jan 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.32 | 10,000 | 903,203 | 225,894 | 235.9 K to 225.9 K (-4.24 %) |
Jan 09 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 235,894 | 225.9 K to 235.9 K (+4.43 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 192,500 | |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 38.59 | 10,000 | 385,900 | 202,500 | |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.61 | 10,000 | 896,125 | 225,894 | 235.9 K to 225.9 K (-4.24 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 235,894 | 225.9 K to 235.9 K (+4.43 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.89 | 10,000 | 898,912 | 225,894 | 235.9 K to 225.9 K (-4.24 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 38.59 | 10,000 | 385,900 | 235,894 | 225.9 K to 235.9 K (+4.43 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 600 | 0 | 225,894 | 226.5 K to 225.9 K (-0.26 %) |
Jan 02 2018 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Gift | G | 0.00 | 430 | 0 | 226,494 | 226.9 K to 226.5 K (-0.19 %) |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 0 | |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 5,000 | |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.56 | 5,000 | 452,800 | 226,924 | 231.9 K to 226.9 K (-2.16 %) |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 231,924 | 226.9 K to 231.9 K (+2.20 %) |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 90.72 | 6,640 | 602,381 | 226,924 | 233.6 K to 226.9 K (-2.84 %) |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.70 | 5,000 | 448,500 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
Jun 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 10,000 | |
Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.53 | 5,000 | 437,650 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
Jun 05 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 7,423 | 128,641 | 15,000 | |
Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.29 | 7,423 | 655,377 | 233,564 | 241 K to 233.6 K (-3.08 %) |
Jun 02 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 7,423 | 128,641 | 240,987 | 233.6 K to 241 K (+3.18 %) |
May 26 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 22,423 | |
May 26 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 88.38 | 5,000 | 441,900 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
May 26 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
May 19 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 27,423 | |
May 19 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.73 | 5,000 | 458,650 | 233,564 | 238.6 K to 233.6 K (-2.10 %) |
May 19 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 238,564 | 233.6 K to 238.6 K (+2.14 %) |
May 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 91.50 | 4,932 | 451,278 | 233,564 | 238.5 K to 233.6 K (-2.07 %) |
May 16 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 32,423 | |
May 16 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.23 | 5,000 | 446,150 | 238,496 | 243.5 K to 238.5 K (-2.05 %) |
May 16 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,496 | 238.5 K to 243.5 K (+2.10 %) |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 37,423 | |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 42,423 | |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 93.17 | 5,000 | 465,850 | 238,496 | 243.5 K to 238.5 K (-2.05 %) |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,496 | 238.5 K to 243.5 K (+2.10 %) |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 99.00 | 5,000 | 495,000 | 238,496 | 243.5 K to 238.5 K (-2.05 %) |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,496 | 238.5 K to 243.5 K (+2.10 %) |
May 09 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 70.30 | 302 | 21,232 | 238,496 | 238.2 K to 238.5 K (+0.13 %) |
May 01 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 47,423 | |
May 01 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 95.72 | 5,000 | 478,600 | 238,194 | 243.2 K to 238.2 K (-2.06 %) |
May 01 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,194 | 238.2 K to 243.2 K (+2.10 %) |
Apr 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 52,423 | |
Apr 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 94.00 | 5,000 | 470,000 | 238,194 | 243.2 K to 238.2 K (-2.06 %) |
Apr 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 243,194 | 238.2 K to 243.2 K (+2.10 %) |
Apr 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 14.39 | 3,000 | 43,170 | 114,000 | |
Apr 06 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 14.39 | 3,000 | 43,170 | 238,194 | 235.2 K to 238.2 K (+1.28 %) |
Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | A | 87.42 | 144,050 | 12,592,851 | 144,050 | |
Mar 24 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Grant | A | 0.00 | 44,520 | 0 | 235,194 | 190.7 K to 235.2 K (+23.35 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 57,423 | |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 62,423 | |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.96 | 5,000 | 459,800 | 190,674 | 195.7 K to 190.7 K (-2.56 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 71.33 | 5,000 | 356,650 | 195,674 | 190.7 K to 195.7 K (+2.62 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 92.50 | 15,690 | 1,451,325 | 190,674 | 206.4 K to 190.7 K (-7.60 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.42 | 5,000 | 457,100 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
Mar 17 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 67,423 | |
Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 92.68 | 5,000 | 463,400 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
Mar 15 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 72,423 | |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 6,000 | 103,980 | 77,423 | |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.09 | 5,000 | 455,450 | 206,364 | 211.4 K to 206.4 K (-2.37 %) |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 211,364 | 206.4 K to 211.4 K (+2.42 %) |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.18 | 6,000 | 541,080 | 206,364 | 212.4 K to 206.4 K (-2.83 %) |
Mar 13 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 6,000 | 103,980 | 212,364 | 206.4 K to 212.4 K (+2.91 %) |
Mar 07 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Payment of Exercise | F | 93.95 | 8,989 | 844,517 | 206,364 | 215.4 K to 206.4 K (-4.17 %) |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 83,423 | |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 5,000 | 86,650 | 88,423 | |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.00 | 5,000 | 420,000 | 170,682 | 175.7 K to 170.7 K (-2.85 %) |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 175,682 | 170.7 K to 175.7 K (+2.93 %) |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 84.44 | 5,000 | 422,200 | 170,682 | 175.7 K to 170.7 K (-2.85 %) |
Jan 27 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 5,000 | 86,650 | 175,682 | 170.7 K to 175.7 K (+2.93 %) |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 93,423 | |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 97,423 | |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.84 | 4,000 | 359,360 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 91.31 | 4,000 | 365,240 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 12 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 101,423 | |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 105,423 | |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 89.79 | 4,000 | 359,160 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.19 | 4,000 | 348,760 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 10 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 109,423 | |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.33 | 4,000 | 69,320 | 113,423 | |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.35 | 4,000 | 333,400 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 83.84 | 4,000 | 335,360 | 170,682 | 174.7 K to 170.7 K (-2.29 %) |
Jan 03 2017 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.33 | 4,000 | 69,320 | 174,682 | 170.7 K to 174.7 K (+2.34 %) |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,743 | 1,847,492 | 140,513 | |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 26.49 | 69,744 | 1,847,519 | 210,256 | |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 85.69 | 69,743 | 5,976,515 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,743 | 1,847,492 | 240,425 | 170.7 K to 240.4 K (+40.86 %) |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 87.56 | 69,744 | 6,106,478 | 170,682 | 240.4 K to 170.7 K (-29.01 %) |
Nov 23 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 26.49 | 69,744 | 1,847,519 | 240,426 | 170.7 K to 240.4 K (+40.86 %) |
Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 17.54 | 41,670 | 730,892 | 0 | |
Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 90.97 | 41,670 | 3,790,795 | 323,368 | 365 K to 323.4 K (-11.42 %) |
Nov 18 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 17.54 | 41,670 | 730,892 | 365,038 | 323.4 K to 365 K (+12.89 %) |
Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 140,000 | |
Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Option Exercise | M | 21.51 | 70,000 | 1,505,700 | 210,000 | |
Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.83 | 70,000 | 5,797,806 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |
Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Buy | M | 21.51 | 70,000 | 1,505,700 | 393,368 | 323.4 K to 393.4 K (+21.65 %) |
Nov 09 2016 | BMRN | BIOMARIN PHARMACEU ... | BIENAIME JEAN JACQUES | Chief Executive Off ... | Sell | S | 82.52 | 70,000 | 5,776,435 | 323,368 | 393.4 K to 323.4 K (-17.80 %) |